What is NOBLE ROMAN'S INC's earnings per share (EPS)?

NOBLE ROMAN'S INC (NROM) reported diluted earnings per share of $0.04 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

NOBLE ROMAN'S INC (NROM) Financials

NROM

Trailing 12 months to June 30, 2026

Revenue $16.6M +8.0% YoY

Net Income $1.2M +166.7% YoY

EPS (Diluted) $0.05 +150.0% YoY

Free Cash Flow $1.6M +95.0% YoY

Market Cap $13.1M as of Sep 15, 2026

Price / Sales 0.8x on $16.6M revenue, trailing 12 months to June 30, 2026

Price / Earnings 11.1x on $1.2M net income, trailing 12 months to June 30, 2026

Price / Book 3.4x on $3.8M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 12, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NROM SEC filings page.

NOBLE ROMAN'S INC (NROM) reported $16.6M in revenue over the twelve months to Jun 30, 2026, up 8.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NROM FY2025 2026-08-30

Debt reduction and cash generation improved, but 2025’s working-capital pressure now dominates Noble Roman’s financing profile.

In FY2025, operating cash flow of $1.2M broadly matched net income of $1.2M, indicating earnings and cash generation were aligned. However, free cash flow of $1.1M coexisted with a current ratio of 0.4x, so annual cash conversion did not prevent tighter near-term obligations.

Operating margin reached 23.9% in FY2023 before falling to 9.7% in FY2024, so the earnings profile is volatile rather than steadily expanding. It recovered to 14.6% in FY2025 while revenue increased, suggesting partial cost absorption rather than a proven structural margin step-up.

Debt-to-equity fell from 24.8x in FY2022 to 1.0x in FY2025, indicating deleveraging has materially rebuilt the equity cushion. But current liabilities of $8.2M exceeded current assets of $3.2M in FY2025, so improved long-term leverage has not removed short-term funding strain.

Financial Health Signals

Financial health score not available

NOBLE ROMAN'S INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-0.10

NOBLE ROMAN'S INC scores -0.10, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($13.1M) relative to total liabilities ($12.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/7

NOBLE ROMAN'S INC passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.06x

For every $1 of reported earnings, NOBLE ROMAN'S INC generates $1.06 in operating cash flow ($1.2M OCF vs $1.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

1.80x

NOBLE ROMAN'S INC earns $1.80 in operating income for every $1 of interest expense ($2.4M vs $1.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.1M

YoY+1.1%

QoQ+5.6%

5Y CAGR+2.8%

10Y CAGR+7.8%

NOBLE ROMAN'S INC generated $4.1M in revenue in Q2 2026. This represents an increase of 1.1% from the same quarter a year earlier. Against the prior quarter it is up 5.6%.

EBITDA

$817K

YoY-11.9%

QoQ+24.9%

5Y CAGR+7.6%

10Y CAGR-1.1%

NOBLE ROMAN'S INC's EBITDA was $817K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 11.9% from the same quarter a year earlier. Against the prior quarter it is up 24.9%.

Net Income

$191K

YoY-33.2%

QoQ-18.0%

5Y CAGR+17.5%

10Y CAGR+19.9%

NOBLE ROMAN'S INC reported $191K in net income in Q2 2026. This represents a decrease of 33.2% from the same quarter a year earlier. Against the prior quarter it is down 18.0%.

EPS (Diluted)

$0.01

YoY0.0%

QoQ0.0%

NOBLE ROMAN'S INC earned $0.01 per diluted share (EPS) in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Cash & Balance Sheet

Free Cash Flow

$771K

YoY+79.7%

QoQ+174.9%

5Y CAGR+39.9%

NOBLE ROMAN'S INC generated $771K in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 79.7% from the same quarter a year earlier. Against the prior quarter it is up 174.9%.

Cash & Debt

$1.1M

YoY+72.3%

QoQ+103.1%

5Y CAGR-11.5%

10Y CAGR+5.8%

NOBLE ROMAN'S INC held $1.1M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

23M

YoY+2.2%

QoQ+2.2%

NOBLE ROMAN'S INC had 23M shares outstanding in Q2 2026. This represents an increase of 2.2% from the same quarter a year earlier. Against the prior quarter it is up 2.2%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Operating Margin

17.3%

YoY-3.0pp

QoQ+3.2pp

5Y change+5.5pp

10Y change-28.1pp

NOBLE ROMAN'S INC's operating margin was 17.3% in Q2 2026, reflecting core business profitability. This is down 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.2 percentage points.

Net Margin

4.6%

YoY-2.4pp

QoQ-1.3pp

5Y change+2.2pp

10Y change+3.0pp

NOBLE ROMAN'S INC's net profit margin was 4.6% in Q2 2026, showing the share of revenue converted to profit. This is down 2.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.3 percentage points.

Return on Equity

5.0%

YoY-6.1pp

QoQ-1.5pp

5Y change+2.4pp

10Y change+4.8pp

NOBLE ROMAN'S INC's ROE was 5.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 6.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.5 percentage points.

Gross Margin

Not reported for Q2 2026.

Capital Allocation

Capital Expenditures

$33K

YoY-24.7%

QoQ-21.2%

5Y CAGR-4.6%

10Y CAGR+36.0%

NOBLE ROMAN'S INC invested $33K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 24.7% from the same quarter a year earlier. Against the prior quarter it is down 21.2%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

NROM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NROM quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$16.6M	$16.5M+8.7%	$15.1M+5.4%	$14.4M-0.5%	$14.5M+4.1%	$13.9M+20.4%	$11.5M-1.4%	$11.7M-6.0%	$12.4M+26.5%	$9.8M+25.5%	$7.8M+1.4%	$7.7M-2.3%	$7.9M+5.2%	$7.5M+3.1%	$7.3M-1.0%	$7.4M
SG&A Expenses	$2.7M	$2.3M-12.7%	$2.7M+72.9%	$1.5M-28.5%	$2.2M+21.1%	$1.8M+4.3%	$1.7M-1.3%	$1.7M+4.2%	$1.7M+0.2%	$1.7M+1.5%	$1.6M-1.1%	$1.7M+0.8%	$1.6M0.0%	$1.6M+3.3%	$1.6M-1.6%	$1.6M
Operating Income	$2.3M	$2.4M+63.1%	$1.5M-57.1%	$3.4M+704.2%	$428K-75.5%	$1.7M-24.7%	$2.3M-11.5%	$2.6M-1.6%	$2.7M-9.7%	$2.9M-4.3%	$3.1M+4.6%	$2.9M-3.2%	$3.0M+6.6%	$2.8M+1.2%	$2.8M-3.7%	$2.9M
EBITDA	N/A	$2.8M+41.7%	$2.0M-48.3%	$3.8M+334.9%	$878K-66.1%	$2.6M-3.9%	$2.7M-10.0%	$3.0M-3.3%	$3.1M-2.7%	$3.2M-0.5%	$3.2M+5.1%	$3.0M-3.3%	$3.2M+6.3%	$3.0M+1.1%	$2.9M-3.8%	$3.0M
Interest Expense	$1.3M	$1.3M-18.4%	$1.6M-6.1%	$1.7M-7.4%	$1.9M+38.4%	$1.4M-28.9%	$1.9M+147.2%	$775K+18.2%	$655K-55.6%	$1.5M+6490.8%	$22K	N/A	N/A	N/A	$46K-40.0%	$76K
Income Tax	$355K	$417K+365.3%	-$157K	$0+100.0%	-$142K-11.7%	-$128K-115.2%	$840K-8.4%	$917K-1.4%	$930K-77.6%	$4.1M+749.9%	$488K-4.8%	$513K-53.6%	$1.1M+94.4%	$568K-24.6%	$753K-24.9%	$1.0M
Net Income	$1.2M	$1.2M+37063.6%	-$3K-100.2%	$1.5M+211.1%	-$1.3M-357.9%	$509K+109.5%	-$5.4M-1323.6%	-$378K+87.7%	-$3.1M+9.5%	-$3.4M-288.7%	-$871K-210.8%	$786K-50.6%	$1.6M+1645.6%	$91K-85.4%	$624K-23.8%	$819K
EPS (Basic)	N/A	$0.05	$0.00-100.0%	$0.07+216.7%	-$0.06-400.0%	$0.02+108.3%	-$0.24-1100.0%	-$0.02+85.7%	-$0.14+12.5%	-$0.16-300.0%	-$0.04-200.0%	$0.04-50.0%	$0.08+700.0%	$0.01-66.7%	$0.03-25.0%	$0.04
EPS (Diluted)	$0.05	$0.04	$0.00-100.0%	$0.07+216.7%	-$0.06-400.0%	$0.02+108.3%	-$0.24-1100.0%	-$0.02+85.7%	-$0.14+12.5%	-$0.16-300.0%	-$0.04-200.0%	$0.04-42.9%	$0.07	$0.01	$0.03-25.0%	$0.04
Diluted Shares (Avg)	N/A	32M+34.2%	24M+1.3%	24M+6.2%	22M-6.0%	24M+0.8%	23M+0.6%	23M-10.6%	26M+1.5%	26M+21.2%	21M-1.1%	21M+1.1%	21M	20M	20M-0.2%	20M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$4.1M+1.1%	$3.9M+3.8%	$4.5M+21.1%	$4.1M+6.8%	$4.1M+4.5%	$3.8M+2.6%	$3.7M+4.8%	$3.9M+3.8%
SG&A Expenses	$607K+28.0%	$623K+44.0%	$962K-0.2%	$468K-17.3%	$474K-16.8%	$432K-25.1%	$964K+6295.1%	$566K+9.0%
Operating Income	$713K-13.8%	$550K+9.7%	$258K+278.2%	$819K+96.6%	$827K+48.1%	$502K+16.1%	$68K-90.2%	$417K-18.9%
EBITDA	$817K-11.9%	$654K-5.4%	$262K+60.3%	$917K+78.9%	$928K+41.8%	$692K+7.4%	$164K-76.3%	$513K-15.9%
Interest Expense	$497K+17.9%	$245K-25.8%	$180K-54.2%	$406K-2.4%	$422K-3.1%	$330K-16.3%	$393K-37.0%	$416K+15.6%
Income Tax	$25K-79.2%	$73K+78.0%	$116K+173.4%	$141K	$120K	$41K	-$157K+42.6%	$0
Net Income	$191K-33.2%	$233K+78.0%	$117K+170.3%	$640K+231.0%	$285K+402.0%	$131K+251.1%	-$167K-249.1%	$193K+25.1%
EPS (Basic)	$0.010.0%	$0.010.0%	$0.00+100.0%	$0.03+200.0%	$0.01	$0.01	-$0.01-200.0%	$0.010.0%
EPS (Diluted)	$0.010.0%	$0.01	$0.00+100.0%	$0.03+200.0%	$0.01	$0.01	-$0.01	$0.010.0%
Diluted Shares (Avg)	23M-8.1%	32M	N/A	26M+7.5%	26M+7.6%	25M+13.8%	N/A	24M+2.4%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

NROM Balance Sheet

NROM quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$15.9M-5.2%	$16.8M-9.3%	$18.5M+0.7%	$18.3M-5.3%	$19.4M+5.2%	$18.4M-3.6%	$19.1M+21.9%	$15.7M-17.0%	$18.9M-5.1%	$19.9M+7.8%	$18.5M+4.0%	$17.8M+8.5%	$16.4M-4.6%	$17.2M-0.4%	$17.2M
Current Assets	$3.2M+8.7%	$3.0M-22.1%	$3.8M+26.4%	$3.0M-15.2%	$3.6M+6.5%	$3.4M+17.4%	$2.9M-13.3%	$3.3M-11.2%	$3.7M-18.4%	$4.6M+7.1%	$4.3M-3.6%	$4.4M+26.6%	$3.5M-6.4%	$3.7M+9.9%	$3.4M
Cash & Equivalents	$534K-24.9%	$710K-18.6%	$872K+11.1%	$786K-37.8%	$1.3M+5.8%	$1.2M+447.5%	$218K+186.3%	$76K-83.5%	$461K-3.5%	$478K+146.3%	$194K-3.2%	$200K+27.0%	$158K+9.3%	$144K-38.1%	$233K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$965K-2.2%	$987K+2.2%	$966K-3.2%	$998K+0.4%	$994K+11.6%	$891K+1.1%	$881K-8.5%	$963K+23.4%	$780K+3.4%	$754K+53.3%	$492K+29.1%	$381K+12.9%	$338K-26.7%	$461K+36.2%	$338K
Accounts Receivable	$742K+26.4%	$587K-49.8%	$1.2M+233.9%	$350K+7.9%	$324K+60.6%	$202K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$278K0.0%	$278K0.0%	$278K0.0%	$278K0.0%	$278K0.0%	$278K0.0%	$278K0.0%	$278K0.0%	$278K0.0%	$278K	$0	N/A	N/A	N/A	N/A
Total Liabilities	$12.5M-14.4%	$14.6M-10.7%	$16.3M-7.6%	$17.6M+7.0%	$16.5M+2.6%	$16.1M+42.5%	$11.3M+49.7%	$7.5M-8.6%	$8.2M+40.1%	$5.9M+63.8%	$3.6M-10.1%	$4.0M-14.5%	$4.7M-2.3%	$4.8M-13.0%	$5.5M
Current Liabilities	$8.2M+147.2%	$3.3M-8.5%	$3.6M+3.5%	$3.5M+122.3%	$1.6M+22.1%	$1.3M-33.4%	$1.9M+38.8%	$1.4M-2.4%	$1.4M-32.8%	$2.1M+46.7%	$1.4M-32.5%	$2.1M+5.4%	$2.0M+15.6%	$1.8M-58.5%	$4.2M
Non-Current Liabilities	$4.3M-62.1%	$11.2M-11.3%	$12.7M-10.4%	$14.1M-5.2%	$14.9M+0.9%	$14.8M+58.2%	$9.3M+52.1%	$6.1M-9.9%	$6.8M+81.3%	$3.8M+75.3%	$2.1M+16.0%	$1.8M-29.9%	$2.6M-12.8%	$3.0M+140.5%	$1.3M
Long-Term Debt	$3.5M-19.7%	$4.4M-15.5%	$5.2M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$3.4M+54.9%	$2.2M+1.1%	$2.2M+208.5%	$710K-75.5%	$2.9M+22.8%	$2.4M-69.9%	$7.8M-3.8%	$8.1M-23.5%	$10.6M-24.0%	$14.0M-5.8%	$14.9M+8.1%	$13.8M+17.6%	$11.7M-5.5%	$12.4M+5.6%	$11.7M
Retained Earnings	-$21.5M+5.2%	-$22.7M0.0%	-$22.6M+6.1%	-$24.1M-10.1%	-$21.9M+2.3%	-$22.4M-31.6%	-$17.0M-2.6%	-$16.6M-21.3%	-$13.7M-32.9%	-$10.3M-9.2%	-$9.4M+7.7%	-$10.2M+13.5%	-$11.8M-0.1%	-$11.8M+4.3%	-$12.3M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$15.6M-3.9%	$15.7M-3.7%	$15.9M-5.2%	$16.1M-4.5%	$16.2M-6.5%	$16.3M-9.5%	$16.8M-9.3%	$16.8M-6.4%
Current Assets	$3.6M+19.5%	$3.4M+23.1%	$3.2M+8.7%	$3.3M+9.5%	$3.0M-4.8%	$2.8M-24.9%	$3.0M-22.1%	$3.0M-15.5%
Cash & Equivalents	$1.1M+72.3%	$539K-4.5%	$534K-24.9%	$720K+30.5%	$636K-20.7%	$565K-51.5%	$710K-18.6%	$551K-2.2%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$996K-0.7%	$1.0M+1.7%	$965K-2.2%	$1.0M+7.5%	$1.0M+1.6%	$983K-1.6%	$987K+2.2%	$966K+2.5%
Accounts Receivable	$705K+6.4%	$773K+46.0%	$742K+26.4%	$723K	$663K	$530K	$587K-49.8%	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$278K0.0%	$278K0.0%	$278K0.0%	$278K0.0%	$278K0.0%	$278K0.0%	$278K0.0%	$278K0.0%
Total Liabilities	$11.8M-12.7%	$12.0M-13.8%	$12.5M-14.4%	$12.7M-12.3%	$13.5M-11.1%	$13.9M-12.4%	$14.6M-10.7%	$14.5M-9.0%
Current Liabilities	$2.7M-14.2%	$8.0M+159.0%	$8.2M+147.2%	$8.2M-10.4%	$3.2M-67.1%	$3.1M-69.6%	$3.3M-8.5%	$9.2M+361.0%
Non-Current Liabilities	$9.1M-12.2%	$4.0M-63.1%	$4.3M-62.1%	$4.5M-15.6%	$10.3M+86.4%	$10.8M+89.4%	$11.2M-11.3%	$5.3M-58.5%
Long-Term Debt	N/A	N/A	$3.5M-19.7%	N/A	N/A	N/A	$4.4M-15.5%	N/A
Total Equity	$3.8M+48.7%	$3.6M+57.2%	$3.4M+54.9%	$3.4M+42.7%	$2.6M+18.3%	$2.3M+7.7%	$2.2M+1.1%	$2.4M+14.2%
Retained Earnings	-$21.2M+4.4%	-$21.2M+5.7%	-$21.5M+5.2%	-$21.5M+4.3%	-$22.2M+2.3%	-$22.5M+0.9%	-$22.7M0.0%	-$22.5M-4.1%

NROM Cash Flow Statement

NROM quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$1.8M	$1.2M+53.0%	$814K-48.1%	$1.6M+5202.0%	$30K-98.1%	$1.5M-9.4%	$1.7M+11.1%	$1.5M+1.9%	$1.5M+405.4%	$293K+119.2%	-$1.5M-451.1%	$436K-34.9%	$670K-61.1%	$1.7M+14.5%	$1.5M+21.7%	$1.2M
Depreciation & Amortization	N/A	$393K-21.4%	$500K+31.7%	$380K-15.8%	$451K-46.9%	$849K+122.0%	$382K-0.1%	$383K-13.0%	$440K+82.8%	$241K+93.0%	$125K+17.9%	$106K-5.3%	$112K-1.6%	$114K-2.3%	$116K-6.2%	$124K
Stock-Based Compensation	N/A	$43K+56.8%	$28K+35.6%	$20K-27.6%	$28K+0.2%	$28K+30.6%	$22K+14.4%	$19K+13.4%	$17K+12.9%	$15K+2.9%	$14K-47.0%	$27K+88.6%	$14K	N/A	N/A	N/A
Capital Expenditures	$156K	$144K+63.3%	$88K+538.7%	$14K-97.3%	$508K-65.0%	$1.4M-30.5%	$2.1M+620.5%	$289K-75.1%	$1.2M-15.4%	$1.4M+277.1%	$364K+2530.3%	$14K-37.6%	$22K+85.4%	$12K-37.0%	$19K+135.7%	$8K
Free Cash Flow	$1.6M	$1.1M+51.8%	$725K-53.3%	$1.6M+425.3%	-$478K-791.2%	$69K+116.9%	-$409K-133.5%	$1.2M+281.3%	$320K+129.6%	-$1.1M+43.0%	-$1.9M-548.9%	$422K-34.8%	$648K-62.1%	$1.7M+15.1%	$1.5M+20.9%	$1.2M
Investing Cash Flow	-$156K	-$144K-63.3%	-$88K-738.7%	$14K+102.7%	-$508K+65.0%	-$1.4M+30.5%	-$2.1M-620.5%	-$289K+75.1%	-$1.2M+15.4%	-$1.4M-277.1%	-$364K-2530.3%	-$14K+37.6%	-$22K-85.4%	-$12K+54.0%	-$26K-81.5%	-$14K
Financing Cash Flow	-$1.2M	-$1.3M-43.9%	-$887K+40.7%	-$1.5M	$0	$0-100.0%	$1.4M+228.6%	-$1.1M-64.5%	-$655K-150.8%	$1.3M-51.7%	$2.7M+816.8%	-$372K+14.1%	-$433K+66.9%	-$1.3M-51.4%	-$863K-40.1%	-$616K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$804K+70.0%	$322K+160.4%	$329K+3.8%	$319K+1253.7%	$473K+633.3%	$124K-77.9%	$317K-38.1%	$24K-96.7%
Depreciation & Amortization	$104K+3.4%	$104K-45.4%	$98K-53.6%	$98K+2.0%	$101K+4.9%	$190K-10.3%	$211K+3410.0%	$96K+0.6%
Stock-Based Compensation	N/A	$14K	N/A	$9K-21.3%	N/A	N/A	N/A	$12K
Capital Expenditures	$33K-24.7%	$42K+115.2%	$30K+41.3%	$51K+121.4%	$44K+73.2%	$19K+3.3%	$21K+31.9%	$23K+6490.0%
Free Cash Flow	$771K+79.7%	$281K+168.8%	$300K+1.1%	$267K+65444.6%	$429K+476.6%	$104K-80.8%	$296K-40.3%	$408-99.9%
Investing Cash Flow	-$33K+24.7%	-$42K-115.2%	-$30K-41.3%	-$51K-121.4%	-$44K-73.2%	-$19K-3.3%	-$21K-148.3%	-$23K-6490.0%
Financing Cash Flow	-$216K+39.8%	-$275K-10.0%	-$485K-253.2%	-$184K+26.6%	-$358K-43.3%	-$250K0.0%	-$137K+44.4%	-$250K+69.9%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

NROM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NROM quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	14.6%+4.9pp	9.7%-14.2pp	23.9%+21.0pp	3.0%-9.6pp	12.6%-7.5pp	20.1%-2.3pp	22.3%+1.0pp	21.3%-8.6pp	29.9%-9.3pp	39.3%+1.2pp	38.0%-0.3pp	38.4%+0.5pp	37.9%-0.7pp	38.6%-1.1pp	39.6%
Net Margin	7.1%+7.2pp	0.0%-10.2pp	10.2%+19.3pp	-9.1%-12.8pp	3.7%+50.3pp	-46.7%-43.4pp	-3.2%+21.4pp	-24.6%+9.8pp	-34.4%-23.3pp	-11.1%-21.3pp	10.2%-9.9pp	20.1%+18.9pp	1.2%-7.3pp	8.6%-2.5pp	11.1%
Return on Equity	34.2%+34.3pp	-0.1%-66.8pp	66.6%+251.7pp	-185.0%-202.6pp	17.6%+245.9pp	-228.3%-223.5pp	-4.8%+32.8pp	-37.6%-5.8pp	-31.8%-25.6pp	-6.2%-11.5pp	5.3%-6.3pp	11.6%+10.8pp	0.8%-4.3pp	5.0%-1.9pp	7.0%
Return on Assets	7.4%+7.4pp	0.0%-7.9pp	7.9%+15.1pp	-7.2%-9.8pp	2.6%+31.9pp	-29.2%-27.2pp	-2.0%+17.5pp	-19.5%-1.6pp	-17.9%-13.5pp	-4.4%-8.6pp	4.3%-4.7pp	8.9%+8.4pp	0.6%-3.1pp	3.6%-1.1pp	4.8%
Current Ratio	0.40-0.5x	0.90-0.2x	1.06+0.2x	0.87-1.4x	2.27-0.3x	2.60+1.1x	1.48-0.9x	2.37-0.2x	2.60+0.5x	2.14-0.8x	2.94+0.9x	2.06+0.3x	1.71-0.4x	2.12+1.3x	0.80
Debt-to-Equity	1.02-1.0x	1.98-0.4x	2.36-22.5x	24.83+19.1x	5.69-1.1x	6.81+5.4x	1.44+0.5x	0.92+0.2x	0.77+0.4x	0.42+0.2x	0.240.0x	0.29-0.1x	0.400.0x	0.39-0.1x	0.47
Asset Turnover	1.04+0.1x	0.90+0.1x	0.780.0x	0.79+0.1x	0.72+0.1x	0.630.0x	0.61-0.2x	0.79+0.3x	0.52+0.1x	0.390.0x	0.420.0x	0.450.0x	0.460.0x	0.430.0x	0.43
FCF Margin	6.7%+1.9pp	4.8%-6.0pp	10.8%+14.1pp	-3.3%-3.8pp	0.5%+4.0pp	-3.5%-14.0pp	10.4%+7.8pp	2.6%+13.5pp	-11.0%+13.2pp	-24.2%-29.6pp	5.5%-2.7pp	8.2%-14.5pp	22.7%+2.4pp	20.3%+3.7pp	16.7%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Margin	17.3%-3.0pp	14.1%+0.8pp	5.8%+3.9pp	19.8%+9.0pp	20.3%+6.0pp	13.3%+1.5pp	1.8%-17.9pp	10.7%-3.0pp
Net Margin	4.6%-2.4pp	6.0%+2.5pp	2.6%+7.1pp	15.4%+10.5pp	7.0%+5.5pp	3.5%+5.8pp	-4.5%-7.7pp	5.0%+0.8pp
Return on Equity	5.0%-6.1pp	6.5%+0.8pp	3.4%+11.0pp	18.9%+10.8pp	11.1%+8.5pp	5.8%+9.9pp	-7.5%-12.6pp	8.2%+0.7pp
Return on Assets	1.2%-0.5pp	1.5%+0.7pp	0.7%+1.7pp	4.0%+2.8pp	1.8%+1.4pp	0.8%+1.3pp	-1.0%-1.6pp	1.1%+0.3pp
Current Ratio	1.33+0.4x	0.42-0.5x	0.40-0.5x	0.40+0.1x	0.96+0.6x	0.89+0.5x	0.90-0.2x	0.32-1.4x
Debt-to-Equity	3.09-2.2x	3.37-2.8x	1.02-1.0x	3.75-2.4x	5.26-1.7x	6.14-1.4x	1.98-0.4x	6.10-1.6x
Asset Turnover	0.260.0x	0.250.0x	0.28+0.1x	0.260.0x	0.250.0x	0.230.0x	0.220.0x	0.230.0x
FCF Margin	18.7%+8.2pp	7.2%+4.4pp	6.7%-1.3pp	6.5%+6.4pp	10.5%+13.4pp	2.8%-12.0pp	8.0%-6.0pp	0.0%-19.0pp

Not reported in any period shown, so not listed: Gross Margin.

Note: The current ratio is below 1.0 (0.40), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
NOBLE ROMAN'S INC NROM	FY2025	$16.5M	$1.2M	7.1%	$13.1M	—
PINSTRIPES HOLDINGS INC A PNST	FY2024	$118.7M	-$6.8M	-5.7%	$6.3M	—
FAST CASUAL CONCEPTS INC FCCI	FY2025	$66K	$792	1.2%	$26.1M	—

Where NOBLE ROMAN'S INC Ranks

Frequently Asked Questions

What is NOBLE ROMAN'S INC's annual revenue?

NOBLE ROMAN'S INC (NROM) reported $16.5M in total revenue for fiscal year 2025. This represents a 8.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is NOBLE ROMAN'S INC's revenue growing?

NOBLE ROMAN'S INC (NROM) revenue grew by 8.7% year-over-year, from $15.1M to $16.5M in fiscal year 2025.

Is NOBLE ROMAN'S INC profitable?

Yes, NOBLE ROMAN'S INC (NROM) reported a net income of $1.2M in fiscal year 2025, with a net profit margin of 7.1%.

What is NOBLE ROMAN'S INC's EBITDA?

NOBLE ROMAN'S INC (NROM) had EBITDA of $2.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does NOBLE ROMAN'S INC have?

As of fiscal year 2025, NOBLE ROMAN'S INC (NROM) had $534K in cash and equivalents against $3.5M in long-term debt.

What is NOBLE ROMAN'S INC's operating margin?

NOBLE ROMAN'S INC (NROM) had an operating margin of 14.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is NOBLE ROMAN'S INC's net profit margin?

NOBLE ROMAN'S INC (NROM) had a net profit margin of 7.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is NOBLE ROMAN'S INC's return on equity (ROE)?

NOBLE ROMAN'S INC (NROM) has a return on equity of 34.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is NOBLE ROMAN'S INC's free cash flow?

NOBLE ROMAN'S INC (NROM) generated $1.1M in free cash flow during fiscal year 2025. This represents a 51.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is NOBLE ROMAN'S INC's operating cash flow?

NOBLE ROMAN'S INC (NROM) generated $1.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are NOBLE ROMAN'S INC's total assets?

NOBLE ROMAN'S INC (NROM) had $15.9M in total assets as of fiscal year 2025, including both current and long-term assets.

What are NOBLE ROMAN'S INC's capital expenditures?

NOBLE ROMAN'S INC (NROM) invested $144K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

What is NOBLE ROMAN'S INC's current ratio?

NOBLE ROMAN'S INC (NROM) had a current ratio of 0.40 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is NOBLE ROMAN'S INC's debt-to-equity ratio?

NOBLE ROMAN'S INC (NROM) had a debt-to-equity ratio of 1.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is NOBLE ROMAN'S INC's return on assets (ROA)?

NOBLE ROMAN'S INC (NROM) had a return on assets of 7.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is NOBLE ROMAN'S INC's P/E ratio?

NOBLE ROMAN'S INC (NROM) trades at 11.1x earnings, its market capitalization divided by net income of $1.2M net income, trailing 12 months to June 30, 2026. The market capitalization is $13.1M as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is NOBLE ROMAN'S INC's price-to-sales ratio?

NOBLE ROMAN'S INC (NROM) trades at 0.8x sales, its market capitalization divided by revenue of $16.6M revenue, trailing 12 months to June 30, 2026. The market capitalization is $13.1M as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is NOBLE ROMAN'S INC's Altman Z-Score?

NOBLE ROMAN'S INC (NROM) has an Altman Z-Score of -0.10, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is NOBLE ROMAN'S INC's Piotroski F-Score?

NOBLE ROMAN'S INC (NROM) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are NOBLE ROMAN'S INC's earnings high quality?

NOBLE ROMAN'S INC (NROM) has an earnings quality ratio of 1.06x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can NOBLE ROMAN'S INC cover its interest payments?

NOBLE ROMAN'S INC (NROM) has an interest coverage ratio of 1.80x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.